213 related articles for article (PubMed ID: 2463384)
21. Characterization of murine polyclonal antisera and monoclonal antibodies generated against intact and denatured human papillomavirus type 1 virions.
Yaegashi N; Jenison SA; Valentine JM; Dunn M; Taichman LB; Baker DA; Galloway DA
J Virol; 1991 Mar; 65(3):1578-83. PubMed ID: 1847474
[TBL] [Abstract][Full Text] [Related]
22. Definition of linear antigenic regions of the HPV16 L1 capsid protein using synthetic virion-like particles.
Zhou J; Sun XY; Davies H; Crawford L; Park D; Frazer IH
Virology; 1992 Aug; 189(2):592-9. PubMed ID: 1379392
[TBL] [Abstract][Full Text] [Related]
23. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region.
Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405
[TBL] [Abstract][Full Text] [Related]
24. Type-specific and cross-reactive antibodies induced by human papillomavirus 31 L1/L2 virus-like particles.
Xu Y; Wang Q; Han Y; Song G; Xu X
J Med Microbiol; 2007 Jul; 56(Pt 7):907-913. PubMed ID: 17577054
[TBL] [Abstract][Full Text] [Related]
25. Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.
Varsani A; Williamson AL; de Villiers D; Becker I; Christensen ND; Rybicki EP
J Virol; 2003 Aug; 77(15):8386-93. PubMed ID: 12857908
[TBL] [Abstract][Full Text] [Related]
26. Humoral immune response recognizes a complex set of epitopes on human papillomavirus type 6 l1 capsomers.
Orozco JJ; Carter JJ; Koutsky LA; Galloway DA
J Virol; 2005 Aug; 79(15):9503-14. PubMed ID: 16014913
[TBL] [Abstract][Full Text] [Related]
27. Identification of immunogenic regions of the major coat protein of human papillomavirus type 16 that contain type-restricted epitopes.
Cason J; Patel D; Naylor J; Lunney D; Shepherd PS; Best JM; McCance DJ
J Gen Virol; 1989 Nov; 70 ( Pt 11)():2973-87. PubMed ID: 2479716
[TBL] [Abstract][Full Text] [Related]
28. Mapping of linear B cell epitopes on capsid proteins of bovine papillomavirus: identification of three external type-restricted epitopes.
Cason J; Kambo PK; Jewers RJ; Chrystie IL; Best JM
J Gen Virol; 1993 Dec; 74 ( Pt 12)():2669-77. PubMed ID: 8277272
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the L1 gene product of human papillomavirus type 16 by expression in a vaccinia virus recombinant.
Browne HM; Churcher MJ; Stanley MA; Smith GL; Minson AC
J Gen Virol; 1988 Jun; 69 ( Pt 6)():1263-73. PubMed ID: 2838573
[TBL] [Abstract][Full Text] [Related]
30. DNA sequence and genome organization of genital human papillomavirus type 6b.
Schwarz E; Dürst M; Demankowski C; Lattermann O; Zech R; Wolfsperger E; Suhai S; zur Hausen H
EMBO J; 1983; 2(12):2341-8. PubMed ID: 6321162
[TBL] [Abstract][Full Text] [Related]
31. Evidence of prevalent genital-type human papillomavirus infections in adults and children.
Jenison SA; Yu XP; Valentine JM; Koutsky LA; Christiansen AE; Beckmann AM; Galloway DA
J Infect Dis; 1990 Jul; 162(1):60-9. PubMed ID: 2162371
[TBL] [Abstract][Full Text] [Related]
32. Expression of human papillomavirus type 6 E1, E2, L1 and L2 open reading frames in Escherichia coli.
Thompson GH; Roman A
Gene; 1987; 56(2-3):289-95. PubMed ID: 2445631
[TBL] [Abstract][Full Text] [Related]
33. Synthetic peptides derived from E7 region of human papillomavirus type 16 used as antigens in ELISA.
Krchnák V; Vágner J; Suchánková A; Krcmár M; Ritterová L; Vonka V
J Gen Virol; 1990 Nov; 71 ( Pt 11)():2719-24. PubMed ID: 2174961
[TBL] [Abstract][Full Text] [Related]
34. A two-site enzyme immunoassay for quantitation of human papillomavirus type 16 particles.
Eklund C; Dillner J
J Virol Methods; 1995 May; 53(1):11-23. PubMed ID: 7635919
[TBL] [Abstract][Full Text] [Related]
35. Expression of the E2 open reading frame of papillomaviruses BPV1 and HPV6b in silkworm by a baculovirus vector.
Tada A; Fuse A; Sekine H; Simizu B; Kondo A; Maeda S
Virus Res; 1988 Mar; 9(4):357-67. PubMed ID: 2837019
[TBL] [Abstract][Full Text] [Related]
36. Targeting synthetic Human Papillomavirus (HPV) L2 disulfide-induced N-terminus conformational epitopes for pan-HPV vaccine development.
Khanal S; Ferraris ED; Zahin M; Joh J; Ghim SJ; Jenson AB
Exp Mol Pathol; 2015 Oct; 99(2):330-4. PubMed ID: 26134615
[TBL] [Abstract][Full Text] [Related]
37. Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2.
Pastrana DV; Gambhira R; Buck CB; Pang YY; Thompson CD; Culp TD; Christensen ND; Lowy DR; Schiller JT; Roden RB
Virology; 2005 Jul; 337(2):365-72. PubMed ID: 15885736
[TBL] [Abstract][Full Text] [Related]
38. Expression of human papillomavirus type 6 and type 16 capsid proteins in bacteria and their antigenic characterization.
Banks L; Matlashewski G; Pim D; Churcher M; Roberts C; Crawford L
J Gen Virol; 1987 Dec; 68 ( Pt 12)():3081-9. PubMed ID: 2826650
[TBL] [Abstract][Full Text] [Related]
39. Identification of conformational epitopes of the BPV-1 capsid recognized by competitive inhibition of sera from infected or immunized animals.
Ghim SJ; Jenson AB
Pathobiology; 1993; 61(3-4):138-44. PubMed ID: 8216835
[TBL] [Abstract][Full Text] [Related]
40. Human papillomavirus type 16 capsids expose multiple type-restricted and type-common antigenic epitopes.
Heino P; Skyldberg B; Lehtinen M; Rantala I; Hagmar B; Kreider JW; Kirnbauer R; Dillner J
J Gen Virol; 1995 May; 76 ( Pt 5)():1141-53. PubMed ID: 7537325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
